Theresa Klümper

Affiliations

Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.

Publications (1)

Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistance.

Experimental hematology & oncology

Avec: Theresa Klümper , Henrike Bruckmueller , Tobias Diewock , Meike Kaehler , Sierk Haenisch , Christiane Pott , Oliver Bruhn , Ingolf Cascorbi

Réseau de co-auteurs

Henrike Bruckmueller 1 collaboration

Tobias Diewock 1 collaboration

Meike Kaehler 1 collaboration

Sierk Haenisch 1 collaboration

Christiane Pott 1 collaboration

Oliver Bruhn 1 collaboration

Ingolf Cascorbi 1 collaboration